October 14, 2022, pharmaceutical stocks set off a wave of stops, stocks rose. As of the close of the day, the pharmaceutical and biological plate soared 7.13%, leading the Shenwan level industry. Medical devices, medical services are up more than 9%, in the Shenwan secondary industry in the front. For the recent medical sector rebound, industry insiders believe that there are three main reasons, one is the marginal improvement in medical procurement policy, the second is the subsidized loan to update and reconstruct the equipment policy to help the new medical infrastructure, the third is the leading shares of the third quarter performance preview.